Brief: MoonLake Immunotherapeutics Q2 EPS USD -0.84
10/08/2026 12:01
BRIEF-MoonLake Immunotherapeutics Q2 EPS USD -0.84 Aug 10 (Reuters) - MoonLake Immunotherapeutics Q2 net income USD -61.805 million.
Recent news on MoonLake Immunotherapeutics
See all newsMoonLake jumps as AbbVie's weak skin drug data eases competition fears
Brief: Moonlake Immunotherapeutics Files For Mixed Shelf Offering, Size Not Disclosed
MoonLake Immunotherapeutics reports results for the quarter ended June 30 - Earnings Summary
MoonLake's psoriatic arthritis drug meets key goals in late-stage trial (updated)
MoonLake's psoriatic arthritis drug meets key goals in late-stage trial